[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Anti-Retroviral Drugs Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application

December 2021 | 103 pages | ID: ABD4FA061E9BEN
Prof Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report describes that the global market size of Anti-Retroviral Drugs is $25.1 billion in 2021, and forecasts to 2026 at a CAGR of 3.6%.

For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA

The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For competitor segment, the report include global key players of Anti-Retroviral Drugs as well as some small players. The information for each competitor include:
Company Profile
Business Information
SWOT Analysis
Revenue, Gross Margin and Market Share

Types Segment:
Nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs)
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Protease inhibitors
Fusion inhibitors
CCR5 antagonists
Post-attachment inhibitors
Integrase strand transfer inhibitors (INSTIs)

Companies Covered:
Gilead Sciences
GSK
Pfizer
Roche
Abbott and Boehringer Ingelheim
etc.

Please ask for sample pages for full companies list

Base Year: 2021
Historical Data: from 2016 to 2020
Forecast Data: from 2021 to 2026

Any special requirements about this report, please let us know and we can provide custom report.
CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Sources
  3.2.1 Data Sources
  3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Anti-Retroviral Drugs Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 HISTORICAL AND FORECAST ANTI-RETROVIRAL DRUGS MARKET IN NORTH AMERICA (2016-2026)

8.1 Anti-Retroviral Drugs Market Size
8.2 Anti-Retroviral Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Anti-Retroviral Drugs Market Size by Type
8.5 Key Countries Analysis
  8.5.1 United States
  8.5.2 Canada
  8.5.3 Mexico

CHAPTER 9 HISTORICAL AND FORECAST ANTI-RETROVIRAL DRUGS MARKET IN SOUTH AMERICA (2016-2026)

9.1 Anti-Retroviral Drugs Market Size
9.2 Anti-Retroviral Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Anti-Retroviral Drugs Market Size by Type
9.5 Key Countries Analysis
  9.5.1 Brazil
  9.5.2 Argentina
  9.5.3 Chile
  9.5.4 Peru

CHAPTER 10 HISTORICAL AND FORECAST ANTI-RETROVIRAL DRUGS MARKET IN ASIA & PACIFIC (2016-2026)

10.1 Anti-Retroviral Drugs Market Size
10.2 Anti-Retroviral Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Anti-Retroviral Drugs Market Size by Type
10.5 Key Countries Analysis
  10.5.1 China
  10.5.2 India
  10.5.3 Japan
  10.5.4 South Korea
  10.5.5 Southest Asia
  10.5.6 Australia

CHAPTER 11 HISTORICAL AND FORECAST ANTI-RETROVIRAL DRUGS MARKET IN EUROPE (2016-2026)

11.1 Anti-Retroviral Drugs Market Size
11.2 Anti-Retroviral Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Anti-Retroviral Drugs Market Size by Type
11.5 Key Countries Analysis
  11.5.1 Germany
  11.5.2 France
  11.5.3 United Kingdom
  11.5.4 Italy
  11.5.5 Spain
  11.5.6 Belgium
  11.5.7 Netherlands
  11.5.8 Austria
  11.5.9 Poland
  11.5.10 Russia

CHAPTER 12 HISTORICAL AND FORECAST ANTI-RETROVIRAL DRUGS MARKET IN MEA (2016-2026)

12.1 Anti-Retroviral Drugs Market Size
12.2 Anti-Retroviral Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Anti-Retroviral Drugs Market Size by Type
12.5 Key Countries Analysis
  12.5.1 Egypt
  12.5.2 Israel
  12.5.3 South Africa
  12.5.4 Gulf Cooperation Council Countries
  12.5.5 Turkey

CHAPTER 13 SUMMARY FOR GLOBAL ANTI-RETROVIRAL DRUGS MARKET (2016-2021)

13.1 Anti-Retroviral Drugs Market Size
13.2 Anti-Retroviral Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Anti-Retroviral Drugs Market Size by Type

CHAPTER 14 GLOBAL ANTI-RETROVIRAL DRUGS MARKET FORECAST (2021-2026)

14.1 Anti-Retroviral Drugs Market Size Forecast
14.2 Anti-Retroviral Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Anti-Retroviral Drugs Type Forecast

CHAPTER 15 ANALYSIS OF GLOBAL KEY VENDORS

15.1 Gilead Sciences
  15.1.1 Company Profile
  15.1.2 Main Business and Anti-Retroviral Drugs Information
  15.1.3 SWOT Analysis of Gilead Sciences
  15.1.4 Gilead Sciences Anti-Retroviral Drugs Revenue, Gross Margin and Market Share (2016-2021)
15.2 GSK
  15.2.1 Company Profile
  15.2.2 Main Business and Anti-Retroviral Drugs Information
  15.2.3 SWOT Analysis of GSK
  15.2.4 GSK Anti-Retroviral Drugs Revenue, Gross Margin and Market Share (2016-2021)
15.3 Pfizer
  15.3.1 Company Profile
  15.3.2 Main Business and Anti-Retroviral Drugs Information
  15.3.3 SWOT Analysis of Pfizer
  15.3.4 Pfizer Anti-Retroviral Drugs Revenue, Gross Margin and Market Share (2016-2021)
15.4 Roche
  15.4.1 Company Profile
  15.4.2 Main Business and Anti-Retroviral Drugs Information
  15.4.3 SWOT Analysis of Roche
  15.4.4 Roche Anti-Retroviral Drugs Revenue, Gross Margin and Market Share (2016-2021)
15.5 Abbott and Boehringer Ingelheim
  15.5.1 Company Profile
  15.5.2 Main Business and Anti-Retroviral Drugs Information
  15.5.3 SWOT Analysis of Abbott and Boehringer Ingelheim
  15.5.4 Abbott and Boehringer Ingelheim Anti-Retroviral Drugs Revenue, Gross Margin and Market Share (2016-2021)
Please ask for sample pages for full companies list
TABLES AND FIGURES

Table Abbreviation and Acronyms
Table Research Scope of Anti-Retroviral Drugs Report
Table Data Sources of Anti-Retroviral Drugs Report
Table Major Assumptions of Anti-Retroviral Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Anti-Retroviral Drugs Picture
Table Anti-Retroviral Drugs Classification
Table Anti-Retroviral Drugs Applications
Table Drivers of Anti-Retroviral Drugs Market
Table Restraints of Anti-Retroviral Drugs Market
Table Opportunities of Anti-Retroviral Drugs Market
Table Threats of Anti-Retroviral Drugs Market
Table Covid-19 Impact For Anti-Retroviral Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Anti-Retroviral Drugs
Table Cost Structure Analysis of Anti-Retroviral Drugs
Table Key End Users
Table Latest News of Anti-Retroviral Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Anti-Retroviral Drugs Market
Table Policy of Anti-Retroviral Drugs Market
Table 2016-2026 North America Anti-Retroviral Drugs Market Size
Figure 2016-2026 North America Anti-Retroviral Drugs Market Size and CAGR
Table 2016-2026 North America Anti-Retroviral Drugs Market Size by Application
Table 2016-2021 North America Anti-Retroviral Drugs Key Players Revenue
Table 2016-2021 North America Anti-Retroviral Drugs Key Players Market Share
Table 2016-2026 North America Anti-Retroviral Drugs Market Size by Type
Table 2016-2026 United States Anti-Retroviral Drugs Market Size
Table 2016-2026 Canada Anti-Retroviral Drugs Market Size
Table 2016-2026 Mexico Anti-Retroviral Drugs Market Size
Table 2016-2026 South America Anti-Retroviral Drugs Market Size
Figure 2016-2026 South America Anti-Retroviral Drugs Market Size and CAGR
Table 2016-2026 South America Anti-Retroviral Drugs Market Size by Application
Table 2016-2021 South America Anti-Retroviral Drugs Key Players Revenue
Table 2016-2021 South America Anti-Retroviral Drugs Key Players Market Share
Table 2016-2026 South America Anti-Retroviral Drugs Market Size by Type
Table 2016-2026 Brazil Anti-Retroviral Drugs Market Size
Table 2016-2026 Argentina Anti-Retroviral Drugs Market Size
Table 2016-2026 Chile Anti-Retroviral Drugs Market Size
Table 2016-2026 Peru Anti-Retroviral Drugs Market Size
Table 2016-2026 Asia & Pacific Anti-Retroviral Drugs Market Size
Figure 2016-2026 Asia & Pacific Anti-Retroviral Drugs Market Size and CAGR
Table 2016-2026 Asia & Pacific Anti-Retroviral Drugs Market Size by Application
Table 2016-2021 Asia & Pacific Anti-Retroviral Drugs Key Players Revenue
Table 2016-2021 Asia & Pacific Anti-Retroviral Drugs Key Players Market Share
Table 2016-2026 Asia & Pacific Anti-Retroviral Drugs Market Size by Type
Table 2016-2026 China Anti-Retroviral Drugs Market Size
Table 2016-2026 India Anti-Retroviral Drugs Market Size
Table 2016-2026 Japan Anti-Retroviral Drugs Market Size
Table 2016-2026 South Korea Anti-Retroviral Drugs Market Size
Table 2016-2026 Southeast Asia Anti-Retroviral Drugs Market Size
Table 2016-2026 Australia Anti-Retroviral Drugs Market Size
Table 2016-2026 Europe Anti-Retroviral Drugs Market Size
Figure 2016-2026 Europe Anti-Retroviral Drugs Market Size and CAGR
Table 2016-2026 Europe Anti-Retroviral Drugs Market Size by Application
Table 2016-2021 Europe Anti-Retroviral Drugs Key Players Revenue
Table 2016-2021 Europe Anti-Retroviral Drugs Key Players Market Share
Table 2016-2026 Europe Anti-Retroviral Drugs Market Size by Type
Table 2016-2026 Germany Anti-Retroviral Drugs Market Size
Table 2016-2026 France Anti-Retroviral Drugs Market Size
Table 2016-2026 United Kingdom Anti-Retroviral Drugs Market Size
Table 2016-2026 Italy Anti-Retroviral Drugs Market Size
Table 2016-2026 Spain Anti-Retroviral Drugs Market Size
Table 2016-2026 Belgium Anti-Retroviral Drugs Market Size
Table 2016-2026 Netherlands Anti-Retroviral Drugs Market Size
Table 2016-2026 Austria Anti-Retroviral Drugs Market Size
Table 2016-2026 Poland Anti-Retroviral Drugs Market Size
Table 2016-2026 Russia Anti-Retroviral Drugs Market Size
Table 2016-2026 MEA Anti-Retroviral Drugs Market Size
Figure 2016-2026 MEA Anti-Retroviral Drugs Market Size and CAGR
Table 2016-2026 MEA Anti-Retroviral Drugs Market Size by Application
Table 2016-2021 MEA Anti-Retroviral Drugs Key Players Revenue
Table 2016-2021 MEA Anti-Retroviral Drugs Key Players Market Share
Table 2016-2026 MEA Anti-Retroviral Drugs Market Size by Type
Table 2016-2026 Egypt Anti-Retroviral Drugs Market Size
Table 2016-2026 Israel Anti-Retroviral Drugs Market Size
Table 2016-2026 South Africa Anti-Retroviral Drugs Market Size
Table 2016-2026 Gulf Cooperation Council Countries Anti-Retroviral Drugs Market Size
Table 2016-2026 Turkey Anti-Retroviral Drugs Market Size
Table 2016-2021 Global Anti-Retroviral Drugs Market Size by Region
Table 2016-2021 Global Anti-Retroviral Drugs Market Size Share by Region
Table 2016-2021 Global Anti-Retroviral Drugs Market Size by Application
Table 2016-2021 Global Anti-Retroviral Drugs Market Share by Application
Table 2016-2021 Global Anti-Retroviral Drugs Key Vendors Revenue
Figure 2016-2021 Global Anti-Retroviral Drugs Market Size and Growth Rate
Table 2016-2021 Global Anti-Retroviral Drugs Key Vendors Market Share
Table 2016-2021 Global Anti-Retroviral Drugs Market Size by Type
Table 2016-2021 Global Anti-Retroviral Drugs Market Share by Type
Table 2021-2026 Global Anti-Retroviral Drugs Market Size by Region
Table 2021-2026 Global Anti-Retroviral Drugs Market Size Share by Region
Table 2021-2026 Global Anti-Retroviral Drugs Market Size by Application
Table 2021-2026 Global Anti-Retroviral Drugs Market Share by Application
Table 2021-2026 Global Anti-Retroviral Drugs Key Vendors Revenue
Figure 2021-2026 Global Anti-Retroviral Drugs Market Size and Growth Rate
Table 2021-2026 Global Anti-Retroviral Drugs Key Vendors Market Share
Table 2021-2026 Global Anti-Retroviral Drugs Market Size by Type
Table 2021-2026 Anti-Retroviral Drugs Global Market Share by Type


More Publications